Awesome ABC pop-up book for kids
Submitted by jhbarr on Tue, 2008-03-25 16:20. booksThis book, ABC3D, is a work of art:
Very cool news
Submitted by jhbarr on Mon, 2008-03-24 23:42. MedicineI only hope people get the difference between this and actually cloning an entire living person, let alone a human being.
At least my hearing indicates I am young
Submitted by jhbarr on Tue, 2008-03-18 17:25. Hearing | Test|
You are about 20 years old
|
|
The teen repellent will no longer foil you, but you can still hear some pretty high tones.
The highest pitched ultrasonic mosquito ringtone that I can hear is 16.7kHz |
| Find out which ultrasonic ringtones you can hear! |
A tattoo I might think about getting
Submitted by jhbarr on Fri, 2008-02-29 18:37. technologyJim Mielke's wireless blood-fueled display is a true merging of technology and body art. At the recent Greener Gadgets Design Competition, the engineer demonstrated a subcutaneously implanted touch-screen that operates as a cell phone display, with the potential for 3G video calls that are visible just underneath the skin.
This was an even cooler part which might get the medical industry interested as well:
Could such an invasive device have harmful biological effects? Actually, the device could offer health benefits. That´s because it also continually monitors for many blood disorders, alerting the person of a health problem.
More info here.
Gever Tulley: 5 dangerous things you should let your kids do
Submitted by jhbarr on Fri, 2008-02-01 06:55. kids | VideoI have watched some really excellent videos from TED about new and exciting areas of research and innovation. However, this one was just interesting and fun. By the way, he actually does six.
Pepsi ad for Superbowl preview show created by deaf workers at Pepsi
Submitted by jhbarr on Thu, 2008-01-31 17:13. deaf | VideoI thought this ad was hilarious!!
News and analysis
Submitted by jhbarr on Tue, 2008-01-15 00:14. funny | recommendationI started watching The Gnooze at the beginning of the year and added it to my RSS reader. Especially, with the Daily Show sans writers, its a welcome addition. Usually two to three stories a day; but the longer end of the year review was hilarious.
Consumer Reports Best Buy Drugs
Submitted by jhbarr on Wed, 2007-11-07 19:44. MedicineFound this interesting website on The Consumerist. If you are on any meds, you may want to look here. Generics are often just as good and oftentimes cheaper than the advertised meds (those with patents that are still good).
The mission of the Consumer Reports Best Buy Drugs project is to provide consumers and their doctors with information to help guide prescription drug choices–based on effectiveness, a drug's track record, safety and price.
The project aims to improve access to needed medicines for tens of millions of Americans—because they lack insurance coverage for prescription drugs, because the prices of many medicines today are so high, and because many consumers and physicians may not be aware of proven and affordable alternatives
Andy Grove's potential impact on PD research
Submitted by jhbarr on Wed, 2007-11-07 07:29. MedicineSaw an interview in Newsweek where the former CEO of Intel has been diagnosed with Parkinson's and he is already making waves with his views on research and comparing it to the computer industry.
I wonder if he could have as much impact on drug research in general and Parkinson's research in particular as Michael J. Fox. One interesting analogy is that Fox took business people from industry and told them he wanted them out of business in 10 years. While this may not happen, he was one of the first to start talking about schedule and time to market which is what Grove is also talking about. It is going to take a paradigm shift to speed up the process and hopefully Grove will help push for that shift.
One major difference is the way the companies seem to utilize and work with their patent portfolios. The chip industry will continue to develop once they achieve a patent to not only improve or refine the design but to innovate new methods and solutions. It seems pharma always reaches an endpoint with a medication and sit on that patent until it runs out. Once the endpoint is reached it is on to a new drug entirely and we do not see the innovation or improvement from year to year.
